Global Diabetic Nephropathy Market By Diabetics Type (Type 1, Type 2) By Diagnosis (Urinary albumin test, Albumin/creatinine ratio, Imaging tests, Kidney biopsy, Others) By Treatment (Drug Treatment (SGLT2 inhibitors, Angiotensin converting enzyme (ACE) inhibitors, Angiotensin receptor blockers (ARBs), Others) Dietary Changes, Dialysis, Kidney Transplant); By End User(Hospitals And Clinics, Diabetes Management Centers, Research Institutes); By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia, Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2022 – 2030

Report ID :AMI-1229 | Category : Healthcare | Published Date : August, 2022 | Pages : 402 | Format :PDF